Elucid has developed a way to predict stroke and cardiovascular event likelihood from CT angiography images and recommend the best therapy available on a patient-by-patient basis.
Blake Richards, CEO of Elucid told Medtech Insight that this technology could address major problems facing current diagnostic methods which...